California pharmacy committee sends proposed CCR §1711 changes on quality‑assurance programs to full board

The California State Board of Pharmacy Enforcement and Compounding Committee on April 16 agreed to refer proposed amendments to Title 16, California Code of Regulations section 1711 — updating quality‑assurance (QA) program requirements for pharmacies — to the full board for consideration and possible rulemaking.

Chair Maria Serpa said staff reorganized and clarified the regulation text, adding requirements that pharmacies adopt policies and procedures defining medication‑error review, notifications to impacted parties, the frequency of aggregate medication‑error reports, and how the pharmacist in charge (PIC) must review both individual and aggregate reports. "I appreciate how staff have reorganized and clarified the information in 1711. The result is a more clear regulation," Serpa said.

Board members broadly supported the move toward system‑level analysis but noted implementation concerns. "I really like the new language. I'm very excited about the move towards analyzing... system level errors," Dr. O said, adding that smaller community pharmacies could struggle with a rapid shift from prescriptive timeframes to a more flexible "standard of care." Dr. O and others urged an FAQ or guidance to ease the transition.

President O cautioned that the word "aggregate" may impose administrative burdens if applied without flexibility. "That is giving me a little bit of a pause... it could cause quite a bit of administrative burden and be very broad," she said, and suggested explicitly permitting systemwide QA programs for organizations that own multiple pharmacies.

Nicole Tibo, who said her federally qualified health center already uses a systemwide compliance program, described how aggregate review identified a software setting that, once corrected, eliminated multiple downstream errors. "It was super helpful even at the individual retail pharmacy," Tibo said, arguing that examples in an FAQ would help smaller operations implement changes.

Public commenters urged broader staff involvement and careful limits on cross‑jurisdictional data sharing. Pharmacy technician Chazny Johnson recommended including technicians in QA workflows and adding verification cues that would alert technicians to unselected medication entries. A former large‑system QA lead who identified himself as having overseen QA for Kaiser Permanente said sharing error reports outside California could jeopardize confidentiality and suggested keeping shared QA analysis within the state to preserve legal shielding from plaintiffs' discovery.

Members also debated whether automated dispensing and packaging machines used inside secured, licensed premises should be exempt from an external QA reporting requirement while retaining internal QA and evaluation. Chair Serpa said inspectors have raised concerns about packaging machines, particularly in large mail‑order operations, and recommended further discussion with the full board.

The committee did not take a final regulatory vote but indicated consensus to refer the draft CCR §1711 amendments and open rulemaking so the full board can consider the draft language and stakeholder input.

Next steps: the proposal will be considered at the full board meeting and, if approved, be subject to the standard rulemaking and additional public comment periods.